Immunohistochemiluminescence Detection: A Quantitative Tool in Breast Cancer HER-2 Status Evaluation

Immunohistochemiluminescence Detection: A Quantitative Tool in Breast Cancer HER-2 Status Evaluation

Her-2 status evaluation in breast cancer has prognostic and treatment response value but its interobserver variation among pathologists is a problem since it is not quantitatively assayed. This study presents an immunohistochemiluminescence method to quantify Her-2 in breast cancer. Anti-Her-2 antib...

Full description

Bibliographic Details
Main Authors:	Moacyr Jesus Barreto de Melo Rêgo, Marina Ferraz Cordeiro, Carmelita de Lima Bezerra Cavalcanti, Luiz Bezerra de Carvalho Junior, Eduardo Isidoro Carneiro Beltrão
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	Disease Markers
Online Access:	http://dx.doi.org/10.3233/DMA-130981

Similar Items

Prognostic and predictive biomarkers for hypoxic regions on breast cancer: advances and challenges Biomarcadores preditivos e prognósticos em regiões hipóxicas do câncer de mama: avanços e desafios
by: Moacyr Jesus Barreto de Melo Rêgo, et al.
Published: (2013-02-01)

Evaluation of Lectins Conjugated to Cryptates of Europium (III) in Human Breast Tissues in Histochemistry
by: Ana Rosa Galdino Bandeira, et al.
Published: (2011-01-01)

EVALUATION OF LECTINS CONJUGATED TO CRYPTATES OF EUROPIUM (III) IN HUMAN BREAST TISSUES IN HISTOCHEMISTRY
by: Ana Rosa Galdino Bandeira, et al.
Published: (2011-10-01)

Tipagem molecular de genes de resistência e virulência associado à expressão gênica em isolados de Acinetobacter baumannii submetidos a antimicrobianos
by: CAVALCANTI, Carmelita de Lima Bezerra
Published: (2018)

Evaluation of WGA and Concanavalin A (Con A) lectin as biomarkers of hepatosplenic schistosomiasis in human biopsies with no evidence of egg-granuloma system Avaliação das lectinas WGA e Con A como biomarcadoras de esquistossomose hepatoesplênica em biopsias humanas sem evidência do sistema ovo-granuloma
by: Moacyr Jesus Barreto de Melo Rêgo, et al.
Published: (2013-06-01)

Evaluation of WGA and Concanavalin A (Con A) lectin as biomarkers of hepatosplenic schistosomiasis in human biopsies with no evidence of egg-granuloma system
by: Moacyr Jesus Barreto de Melo Rêgo, et al.
Published: (2013-06-01)

Avaliação do glicocódigo do carcinoma ductal invasivo mamário e sua correlação com dados clínicos e histopatológicos Exploring the glycocode of invasive ductal carcinoma and its correlation with clinical and histopathological data
by: Moacyr Jesus Barreto de Melo Rêgo
Published: (2009-12-01)

Avaliação de aspectos glicobiológicos em ambientes hipóxicos e / ou privados de nutrientes em câncer de mama e sua possível aplicação em diagnóstico e prognóstico
by: RÊGO, Moacyr Jesus Barreto de Melo
Published: (2017)

Carcinoma ductal invasivo mamário esporádico: uma abordagem histoquímica e imunohistiquímica
by: Jesus Barreto de Melo Rêgo, Moacyr
Published: (2014)

Assessment of changes in the brca2 and p53 genes in breast invasive ductal carcinoma in northeast Brazil
by: Eduardo AVF Ramalho, et al.
Published: (2014-01-01)

Reproducibility in the automated quantitative assessment of HER2/neu for breast cancer
by: Tyler Keay, et al.
Published: (2013-01-01)

Assessment of HER-2 status in invasive breast cancer in Brazil
by: Victor Eduardo Arrua Arias, et al.

Quantitative real-time RT-PCR and chromogenic <it>in situ </it>hybridization: precise methods to detect HER-2 status in breast carcinoma
by: Soares Fernando A, et al.
Published: (2009-03-01)

Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
by: Laidi F, et al.
Published: (2014-07-01)

Comparison between Real-Time Quantitative PCR Detection of HER2 mRNA Copy Number in Peripheral Blood and ELISA of Serum HER2 Protein for Determining HER2 Status in Breast Cancer Patients
by: Maria Savino, et al.
Published: (2009-01-01)

In Situ Hybridization Status of 568 Cases of HER2 Equivocal Breast Cancer
by: JIANG Yi'na, et al.
Published: (2019-07-01)

HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation
by: Soomin Ahn, et al.
Published: (2020-01-01)

Ultrasound findings in prediction of breast cancer histological grade and HER2 status
by: Khaleel I. Mohson
Published: (2016-04-01)

Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method.
by: Yalai Bai, et al.
Published: (2013-01-01)

<b>PVA-Glutaraldehyde as support for lectin immobilization and affinity chromatography
by: Moacyr Jesus Barreto de Melo Rêgo, et al.
Published: (2016-12-01)

Status of estrogene, progesterone receptors and HER-2/neu expression in invasive breast cancer
by: Naghshvar F, et al.
Published: (2007-01-01)

The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
by: Hengqiang Zhao, et al.
Published: (2021-05-01)

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor
by: Nick Beije, et al.
Published: (2016-11-01)

The Hierarchical Modular Structure of HER2+ Breast Cancer Network
by: Sergio Antonio Alcalá-Corona, et al.
Published: (2018-10-01)

Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+ Breast Cancer
by: Anum K. Syed, et al.
Published: (2019-01-01)

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
by: Avisek Majumder, et al.
Published: (2021-04-01)

Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases
by: Gabriele Zoppoli, et al.
Published: (2017-05-01)

Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies
by: Inês de Paula Costa Monteiro
Published: (2019)

Effects of HER2 status on the prognosis of male breast cancer: a population-based study
by: Chen L, et al.
Published: (2019-09-01)

Breast Cancer Subtypes among Iraqi Patients: Identified By Their ER, PR and HER2 Status
by: Nada A.S. Alwan, et al.
Published: (2018-01-01)

Metastatic Breast Cancer Survival according to HER2 and Topo2a Gene Status
by: N. Todorović-Raković, et al.
Published: (2009-01-01)

Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients
by: Henry L. Gómez, et al.
Published: (2010-07-01)

HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study
by: Altuna Halilovic, et al.
Published: (2019-08-01)

Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer
by: Masuda Norikazu, et al.
Published: (2010-02-01)

EGFR Expression in HER2-Driven Breast Cancer Cells
by: Florian Weinberg, et al.
Published: (2020-11-01)

Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status
by: Hecheng Lu, et al.
Published: (2020-04-01)

Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
by: F.E. Rosa, et al.
Published: (2013-03-01)

Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
by: F.E. Rosa, et al.
Published: (2013-01-01)

Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
by: Qi Minfang, et al.
Published: (2009-11-01)

HER 2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
by: Hemlata S Shirsat, et al.
Published: (2012-01-01)

Cannot write session to /tmp/vufind_sessions/sess_4k79balqstcg7uue1ot4fekviq